| The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer W Xu, T Neill, Y Yang, Z Hu, E Cleveland, Y Wu, R Hutten, X Xiao, ... Gene therapy 22 (3), 247-256, 2015 | 91 | 2015 |
| Systemic delivery of an oncolytic adenovirus expressing decorin for the treatment of breast cancer bone metastases Y Yang, W Xu, T Neill, Z Hu, CH Wang, X Xiao, SR Stock, T Guise, ... Human gene therapy 26 (12), 813-825, 2015 | 68 | 2015 |
| Decorin-modified umbilical cord mesenchymal stem cells (MSCs) attenuate radiation-induced lung injuries via regulating inflammation, fibrotic factors, and immune responses D Liu, F Kong, Y Yuan, P Seth, W Xu, H Wang, F Xiao, L Wang, Q Zhang, ... International Journal of Radiation Oncology* Biology* Physics 101 (4), 945-956, 2018 | 59 | 2018 |
| Cdc42 regulates microtubule‐dependent Golgi positioning H Hehnly, W Xu, JL Chen, M Stamnes Traffic 11 (8), 1067-1078, 2010 | 51 | 2010 |
| Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality H Yin, A Stojanovic-Terpo, W Xu, A Corken, A Zakharov, F Qian, ... Arteriosclerosis, thrombosis, and vascular biology 33 (11), 2529-2537, 2013 | 47 | 2013 |
| An oncolytic adenovirus targeting transforming growth factor β inhibits protumorigenic signals and produces immune activation: a novel approach to enhance anti-PD-1 and anti … Y Yang, W Xu, D Peng, H Wang, X Zhang, H Wang, F Xiao, Y Zhu, Y Ji, ... Human gene therapy 30 (9), 1117-1132, 2019 | 40 | 2019 |
| Ad5/48 hexon oncolytic virus expressing sTGFβRIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases W Xu, Z Zhang, Y Yang, Z Hu, CH Wang, M Morgan, Y Wu, R Hutten, ... Molecular therapy 22 (8), 1504-1517, 2014 | 35 | 2014 |
| An oncolytic adenovirus encoding decorin and granulocyte macrophage colony stimulating factor inhibits tumor growth in a colorectal tumor model by targeting pro-tumorigenic … Z Liu, Y Yang, X Zhang, H Wang, W Xu, H Wang, F Xiao, Z Bai, H Yao, ... Human Gene Therapy 28 (8), 667-680, 2017 | 32 | 2017 |
| The actin-depolymerizing factor homology and charged/helical domains of drebrin and mAbp1 direct membrane binding and localization via distinct interactions with actin W Xu, M Stamnes Journal of biological chemistry 281 (17), 11826-11833, 2006 | 30 | 2006 |
| Oncolytic adenovirus rAd. DCN inhibits breast tumor growth and lung metastasis in an immune-competent orthotopic xenograft model H Zhao, H Wang, F Kong, W Xu, T Wang, F Xiao, L Wang, D Huang, ... Human Gene Therapy 30 (2), 197-210, 2019 | 26 | 2019 |
| SUMO-specific cysteine protease 1 promotes epithelial mesenchymal transition of prostate cancer cells via regulating SMAD4 deSUMOylation X Zhang, H Wang, H Wang, F Xiao, P Seth, W Xu, Q Jia, C Wu, Y Yang, ... International journal of molecular sciences 18 (4), 808, 2017 | 23 | 2017 |
| LyP-1-modified oncolytic adenoviruses targeting transforming growth factor β inhibit tumor growth and metastases and augment immune checkpoint inhibitor therapy in breast … W Xu, Y Yang, Z Hu, M Head, KA Mangold, M Sullivan, E Wang, P Saha, ... Human gene therapy 31 (15-16), 863-880, 2020 | 17 | 2020 |
| In Vitro Reconstitution of ARF‐Regulated Cytoskeletal Dynamics on Golgi Membranes JL Chen, W Xu, M Stamnes Methods in enzymology 404, 345-358, 2005 | 11 | 2005 |
| Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice S Dai, Y Lv, W Xu, Y Yang, C Liu, X Dong, H Zhang, BS Prabhakar, ... Cancer Gene Therapy 27 (12), 923-933, 2020 | 8 | 2020 |
| The reconstitution of actin polymerization on liposomes M Stamnes, W Xu Liposomes: Methods and Protocols, Volume 2: Biological Membrane Models, 95-103, 2010 | 3 | 2010 |
| 417. Intratumoral delivery of oncolytic adenovirus expressing decorin inhibits growth and metastases of 4T1 breast tumors in syngeneic immune competent BALB/c mice model W Xu, Y Yang, T Neill, H Wang, CH Wang, CO Yun, T Guise, CB Brendler, ... Molecular Therapy 24, S165-S166, 2016 | 2 | 2016 |
| The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model SC Shin, RE Vickman, B Filimon, Y Yang, Z Hu, KA Mangold, ... Cancer Gene Therapy, 1-12, 2024 | | 2024 |
| Immune response markers following combination treatment with oncolytic adenovirus AMUN-003 and immune checkpoint inhibitors in a murine model of triple negative breast cancer SC Shin, B Filimon, Y Yang, Z Hu, VK Gadi, W Xu Cancer Research 83 (7_Supplement), 5078-5078, 2023 | | 2023 |
| Abstract PD2-03: Targeting TGF-β and over-expressing GM-CSF in the Tumor Microenvironment (TME) with AMUN-003 Inhibits Tumor Growth and Metastases and Augments Immune … S Shin, B Filimon, Y Yang, Z Hu, P Seth, VK Gadi, W Xu Cancer Research 83 (5_Supplement), PD2-03-PD2-03, 2023 | | 2023 |
| SUMO-Specific Cysteine Protease 1 Promotes X Zhang, H Wang, H Wang, F Xiao, P Seth, W Xu, Q Jia, C Wu, Y Yang, ... Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer 18, 53, 2018 | | 2018 |
